The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Specific Lipopolysaccharide Found in Cystic Fibrosis Airway Pseudomonas aeruginosa
Abstract
Cystic fibrosis (CF) patients develop chronic airway infections with Pseudomonas aeruginosa (PA). Pseudomonas aeruginosa synthesized lipopolysaccharide (LPS) with a variety of penta- and hexa-acylated lipid A structures under different environmental conditions. CF patient PA synthesized LPS with specific lipid A structures indicating unique recognition of the CF airway environment. CF-specific lipid A forms containing palmitate and aminoarabinose were associated with resistance to cationic antimicrobial peptides and increased inflammatory responses, indicating that they are likely to be involved in airway disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia
Govan, J. R. W., & Deretic, V. P. (1996) · Microbiological Reviews · doi:10.1128/mmbr.60.3.539-574.1996 · Cited by 1,812
A two-component regulatory system (phoP phoQ) controls Salmonella typhimurium virulence.
Miller, S. I., Kukral, A. M., & Mekalanos, J. J. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.13.5054 · Cited by 929
Self-citationMg2+ as an Extracellular Signal: Environmental Regulation of Salmonella Virulence
Véscovi, E. G., Soncini, F. C., & Groisman, E. A. (1996) · Cell · doi:10.1016/s0092-8674(00)81003-x · Cited by 841
Gunn, J. S., Lim, K. B., Krueger, J., Kim, K., Guo, L., Hackett, M., & Miller, S. I. (1998) · Molecular Microbiology · doi:10.1046/j.1365-2958.1998.00757.x · Cited by 655
Self-citationLipid A Acylation and Bacterial Resistance against Vertebrate Antimicrobial Peptides
Guo, L., Lim, K. B., Poduje, C. M., Daniel, M., Gunn, J. S., Hackett, M., & Miller, S. I. (1998) · Cell · doi:10.1016/s0092-8674(00)81750-x · Cited by 649
Self-citationDarveau, R. P., & Hancock, R. E. (1983) · Journal of Bacteriology · doi:10.1128/jb.155.2.831-838.1983 · Cited by 617
Regulation of Lipid A Modifications by Salmonella typhimurium Virulence Genes phoP-phoQ
Guo, L., Lim, K. B., Gunn, J. S., Bainbridge, B., Darveau, R. P., Hackett, M., & Miller, S. I. (1997) · Science · doi:10.1126/science.276.5310.250 · Cited by 559
Self-citation[22] Electrospray ionization mass spectrometry
Edmonds, C. G., & Smith, R. D. (1990) · Methods in Enzymology · doi:10.1016/0076-6879(90)93430-s · Cited by 508
Gunn, J. S., & Miller, S. I. (1996) · Journal of Bacteriology · doi:10.1128/jb.178.23.6857-6864.1996 · Cited by 409
Self-citationProtegrin-1: a broad-spectrum, rapidly microbicidal peptide with in vivo activity
Steinberg, D. A., Hurst, M. A., Fujii, C. A., Kung, A. H., Ho, J. F., Cheng, F. C., Loury, D. J., & Fiddes, J. C. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.8.1738 · Cited by 384
Cited by
Raetz, C. R. H., & Whitfield, C. (2002) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.71.110601.135414 · Cited by 4,404
Molecular Basis of Bacterial Outer Membrane Permeability Revisited
Nikaido, H. (2003) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.67.4.593-656.2003 · Cited by 4,316
Mechanisms of Antimicrobial Peptide Action and Resistance
Yeaman, M. R., & Yount, N. Y. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.1.2 · Cited by 3,001
Qin, S., Xiao, W., Zhou, C., Pu, Q., Deng, X., Lan, L., Liang, H., Song, X., & Wu, M. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01056-1 · Cited by 1,703
Pathophysiology and Management of Pulmonary Infections in Cystic Fibrosis
Gibson, R. L., Burns, J. L., & Ramsey, B. W. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200304-505so · Cited by 1,633
Self-citationPseudomonas aeruginosa : new insights into pathogenesis and host defenses
Gellatly, S. L., & Hancock, R. E. W. (2013) · Pathogens and Disease · doi:10.1111/2049-632x.12033 · Cited by 1,295
“Similarly both types of changes and especially aminoarabinose addition to either or both phosphates can contribute to resistance to cationic antimicrobial peptides such as polymyxins (Ernst et al., 1999).”
BackgroundBeceiro, A., Tomás, M., & Bou, G. (2013) · Clinical Microbiology Reviews · doi:10.1128/cmr.00059-12 · Cited by 1,070
LPS, TLR4 and infectious disease diversity
Miller, S. I., Ernst, R. K., & Bader, M. W. (2005) · Nature Reviews Microbiology · doi:10.1038/nrmicro1068 · Cited by 998
Self-citationCationic peptides: effectors in innate immunity and novel antimicrobials
Hancock, R. E. (2001) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(01)00092-5 · Cited by 978
Virulence and Immunomodulatory Roles of Bacterial Outer Membrane Vesicles
Ellis, T. N., & Kuehn, M. J. (2010) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00031-09 · Cited by 955
Pseudomonas Aeruginosa: Resistance to the Max
Poole, K. (2011) · Frontiers in Microbiology · doi:10.3389/fmicb.2011.00065 · Cited by 948
The Pleiotropic Two-Component Regulatory System PhoP-PhoQ
Groisman, E. A. (2001) · Journal of Bacteriology · doi:10.1128/jb.183.6.1835-1842.2001 · Cited by 887
Pathogen–Host Interactions in Pseudomonas aeruginosa Pneumonia
Sadikot, R. T., Blackwell, T. S., Christman, J. W., & Prince, A. S. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200408-1044so · Cited by 799
Human Toll-like receptor 4 recognizes host-specific LPS modifications
Hajjar, A. M., Ernst, R. K., Tsai, J. H., Wilson, C. B., & Miller, S. I. (2002) · Nature Immunology · doi:10.1038/ni777 · Cited by 579
Self-citationFujihara, M., Muroi, M., Tanamoto, K.-I., Suzuki, T., Azuma, H., & Ikeda, H. (2003) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2003.08.003 · Cited by 574
Recognition of Antimicrobial Peptides by a Bacterial Sensor Kinase
Bader, M. W., Sanowar, S., Daley, M. E., Schneider, A. R., Cho, U., Xu, W., Klevit, R. E., Le Moual, H., & Miller, S. I. (2005) · Cell · doi:10.1016/j.cell.2005.05.030 · Cited by 567
Self-citationFortifying the barrier: the impact of lipid A remodelling on bacterial pathogenesis
Needham, B. D., & Trent, M. S. (2013) · Nature Reviews Microbiology · doi:10.1038/nrmicro3047 · Cited by 565
Peptidomimetic Antibiotics Target Outer-Membrane Biogenesis in Pseudomonas aeruginosa
Srinivas, N., Jetter, P., Ueberbacher, B. J., Werneburg, M., Zerbe, K., Steinmann, J., Van der Meijden, B., Bernardini, F., Lederer, A., Dias, R. L. A., et al. (2010) · Science · doi:10.1126/science.1182749 · Cited by 554
Innate immune sensing of pathogens and danger signals by cell surface Toll-like receptors
Miyake, K. (2007) · Seminars in Immunology · doi:10.1016/j.smim.2006.12.002 · Cited by 522
Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and impact on treatment
Hancock, R. E. W., & Speert, D. P. (2000) · Drug Resistance Updates · doi:10.1054/drup.2000.0152 · Cited by 515
Darveau, R. P., Pham, T.-T. T., Lemley, K., Reife, R. A., Bainbridge, B. W., Coats, S. R., Howald, W. N., Way, S. S., & Hajjar, A. M. (2004) · Infection and Immunity · doi:10.1128/iai.72.9.5041-5051.2004 · Cited by 507
Epithelial antimicrobial peptides in host defense against infection
Bals, R. (2000) · Respiratory Research · doi:10.1186/rr25 · Cited by 498
Eukaryotic control on bacterial cell cycle and differentiation in the Rhizobium –legume symbiosis
Mergaert, P., Uchiumi, T., Alunni, B., Evanno, G., Cheron, A., Catrice, O., Mausset, A.-E., Barloy-Hubler, F., Galibert, F., Kondorosi, A., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0600912103 · Cited by 491
Pamp, S. J., Gjermansen, M., Johansen, H. K., & Tolker‐Nielsen, T. (2008) · Molecular Microbiology · doi:10.1111/j.1365-2958.2008.06152.x · Cited by 486
Cystic fibrosis: a mucosal immunodeficiency syndrome
Cohen, T. S., & Prince, A. (2012) · Nature Medicine · doi:10.1038/nm.2715 · Cited by 484
Tseng, B. S., Zhang, W., Harrison, J. J., Quach, T. P., Song, J. L., Penterman, J., Singh, P. K., Chopp, D. L., Packman, A. I., & Parsek, M. R. (2013) · Environmental Microbiology · doi:10.1111/1462-2920.12155 · Cited by 466
“All rights reserved. hypothesized that since a phoQ deletion mutant has a more negatively charged LPS 156 than that of wild type (Guo et al., 1997; Ernst et al., 1999), the mutant biofilm may 157 further decrease tobramycin penetration.”
BackgroundHow do bacteria resist human antimicrobial peptides?
Peschel, A. (2002) · Trends in Microbiology · doi:10.1016/s0966-842x(02)02333-8 · Cited by 465
Innate Immunity in the Respiratory Epithelium
Parker, D., & Prince, A. (2011) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2011-0011rt · Cited by 456
Adams, M. D., Nickel, G. C., Bajaksouzian, S., Lavender, H., Murthy, A. R., Jacobs, M. R., & Bonomo, R. A. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00284-09 · Cited by 448
Exacerbations in cystic fibrosis {middle dot} 1: Epidemiology and pathogenesis
Goss, C. H., & Burns, J. L. (2007) · Thorax · doi:10.1136/thx.2006.060889 · Cited by 445
Self-citationMcPhee, J. B., Lewenza, S., & Hancock, R. E. W. (2003) · Molecular Microbiology · doi:10.1046/j.1365-2958.2003.03673.x · Cited by 443
Proteinases of common pathogenic bacteria degrade and inactivate the antibacterial peptide LL‐37
Schmidtchen, A., Frick, I., Andersson, E., Tapper, H., & Björck, L. (2002) · Molecular Microbiology · doi:10.1046/j.1365-2958.2002.03146.x · Cited by 439
Cathelicidins - a family of multifunctional antimicrobial peptides
Bals, R., & Wilson, J. M. (2003) · Cellular and Molecular Life Sciences (CMLS) · doi:10.1007/s00018-003-2186-9 · Cited by 427
Moskowitz, S. M., Ernst, R. K., & Miller, S. I. (2004) · Journal of Bacteriology · doi:10.1128/jb.186.2.575-579.2004 · Cited by 418
Self-citationClinical Significance of Microbial Infection and Adaptation in Cystic Fibrosis
Hauser, A. R., Jain, M., Bar-Meir, M., & McColley, S. A. (2011) · Clinical Microbiology Reviews · doi:10.1128/cmr.00036-10 · Cited by 411
Gram-positive and gram-negative bacterial toxins in sepsis: A brief review
Ramachandran, G. (2014) · Virulence · doi:10.4161/viru.27024 · Cited by 411
Gunn, J. S., Ryan, S. S., van Velkinburgh, J. C., Ernst, R. K., & Miller, S. I. (2000) · Infection and Immunity · doi:10.1128/.68.11.6139-6146.2000 · Cited by 398
Self-citationTransfer of palmitate from phospholipids to lipid A in outer membranes of Gram-negative bacteria
Bishop, R. E., Gibbons, H. S., Guina, T., Trent, M. S., Miller, S. I., & Raetz, C. R. H. (2000) · The EMBO Journal · doi:10.1093/emboj/19.19.5071 · Cited by 388
Self-citationBeceiro, A., Llobet, E., Aranda, J., Bengoechea, J. A., Doumith, M., Hornsey, M., Dhanji, H., Chart, H., Bou, G., Livermore, D. M., et al. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00079-11 · Cited by 379
Microcolony formation: a novel biofilm model of Pseudomonas aeruginosa for the cystic fibrosis lung
Sriramulu, D. D., Lünsdorf, H., Lam, J. S., & Römling, U. (2005) · Journal of Medical Microbiology · doi:10.1099/jmm.0.45969-0 · Cited by 366
Targeting mechanisms of Pseudomonas aeruginosa pathogenesis
Kipnis, E., Sawa, T., & Wiener-Kronish, J. (2006) · Médecine et Maladies Infectieuses · doi:10.1016/j.medmal.2005.10.007 · Cited by 353
Gooderham, W. J., & Hancock, R. E. W. (2009) · FEMS Microbiology Reviews · doi:10.1111/j.1574-6976.2008.00135.x · Cited by 346
Solution structure and dynamics of the outer membrane enzyme PagP by NMR
Hwang, P. M., Choy, W.-Y., Lo, E. I., Chen, L., Forman-Kay, J. D., Raetz, C. R. H., Privé, G. G., Bishop, R. E., & Kay, L. E. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.212344499 · Cited by 329
Fernández, L., Gooderham, W. J., Bains, M., McPhee, J. B., Wiegand, I., & Hancock, R. E. W. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00242-10 · Cited by 320
Bauman, S. J., & Kuehn, M. J. (2006) · Microbes and Infection · doi:10.1016/j.micinf.2006.05.001 · Cited by 316
Review: Lipopolysaccharide biosynthesis in Pseudomonas aeruginosa
King, J. D., Kocíncová, D., Westman, E. L., & Lam, J. S. (2009) · Innate Immunity · doi:10.1177/1753425909106436 · Cited by 312
Antimicrobial Peptides: Current Status and Therapeutic Potential
Koczulla, A. R., & Bals, R. (2003) · Drugs · doi:10.2165/00003495-200363040-00005 · Cited by 306
Analysis of Nonvolatile Lipids by Mass Spectrometry
Murphy, R. C., Fiedler, J., & Hevko, J. (2001) · Chemical Reviews · doi:10.1021/cr9900883 · Cited by 304
Erickson, D. L., Endersby, R., Kirkham, A., Stuber, K., Vollman, D. D., Rabin, H. R., Mitchell, I., & Storey, D. G. (2002) · Infection and Immunity · doi:10.1128/iai.70.4.1783-1790.2002 · Cited by 302
Genetic and Functional Diversity of Pseudomonas aeruginosa Lipopolysaccharide
Lam, J. S., Taylor, V. L., Islam, S. T., Hao, Y., & Kocíncová, D. (2011) · Frontiers in Microbiology · doi:10.3389/fmicb.2011.00118 · Cited by 298
Human β-Defensins 2 and 3 Demonstrate Strain-Selective Activity against Oral Microorganisms
Joly, S., Maze, C., McCray, P. B., & Guthmiller, J. M. (2004) · Journal of Clinical Microbiology · doi:10.1128/jcm.42.3.1024-1029.2004 · Cited by 291
Antimicrobial Peptide Resistance Mechanisms of Human Bacterial Pathogens
(2006) · Current Issues in Molecular Biology · doi:10.21775/cimb.008.011 · Cited by 289
Sheldon, I. M., Rycroft, A. N., Dogan, B., Craven, M., Bromfield, J. J., Chandler, A., Roberts, M. H., Price, S. B., Gilbert, R. O., & Simpson, K. W. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009192 · Cited by 287
Recognition of lipid A variants by the TLR4-MD-2 receptor complex
Maeshima, N., & Fernandez, R. C. (2013) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2013.00003 · Cited by 280
Advances in antimicrobial peptide immunobiology
Yount, N. Y., Bayer, A. S., Xiong, Y. Q., & Yeaman, M. R. (2006) · Peptide Science · doi:10.1002/bip.20543 · Cited by 278
Enhanced Pseudomonas aeruginosa Biofilm Development Mediated by Human Neutrophils
Walker, T. S., Tomlin, K. L., Worthen, G. S., Poch, K. R., Lieber, J. G., Saavedra, M. T., Fessler, M. B., Malcolm, K. C., Vasil, M. L., & Nick, J. A. (2005) · Infection and Immunity · doi:10.1128/iai.73.6.3693-3701.2005 · Cited by 263
Infectious disease: Connecting innate immunity to biocidal polymers
Gabriel, G. J., Som, A., Madkour, A. E., Eren, T., & Tew, G. N. (2007) · Materials Science and Engineering: R: Reports · doi:10.1016/j.mser.2007.03.002 · Cited by 264
Treweek, J. B., Chan, K. Y., Flytzanis, N. C., Yang, B., Deverman, B. E., Greenbaum, A., Lignell, A., Xiao, C., Cai, L., Ladinsky, M. S., et al. (2015) · Nature Protocols · doi:10.1038/nprot.2015.122 · Cited by 258
Adaptation of Pseudomonas aeruginosa during persistence in the cystic fibrosis lung
Hogardt, M., & Heesemann, J. (2010) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2010.08.008 · Cited by 257
The Role of Inflammation in the Pathophysiology of CF Lung Disease
Chmiel, J. F., Berger, M., & Konstan, M. W. (2002) · Clinical Reviews in Allergy & Immunology · doi:10.1385/criai:23:1:005 · Cited by 255
Variation in lipid A structure in the pathogenic yersiniae
Rebeil, R., Ernst, R. K., Gowen, B. B., Miller, S. I., & Hinnebusch, B. J. (2004) · Molecular Microbiology · doi:10.1111/j.1365-2958.2004.04059.x · Cited by 255
Self-citationChmiel, J. F., & Davis, P. B. (2003) · Respiratory Research · doi:10.1186/1465-9921-4-8 · Cited by 254
PIER, G. (2007) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2007.03.012 · Cited by 253
Sensing Gram-Negative Bacterial Lipopolysaccharides: a Human Disease Determinant?
Munford, R. S. (2008) · Infection and Immunity · doi:10.1128/iai.00939-07 · Cited by 189
Holzinger, J. M., Toelge, M., Werner, M., Ederer, K. U., Siegmund, H. I., Peterhoff, D., Blaas, S. H., Gisch, N., Brochhausen, C., Gessner, A., et al. (2023) · eLife · doi:10.7554/elife.86369 · Cited by 4
Metadata
- Authors
- Ernst, R. K., Yi, E. C., Guo, L., Lim, K. B., Burns, J. L., Hackett, M., & Miller, S. I.
- Venue
- Science
- Published
- 1999-11-19
- Volume
- 286
- Issue
- 5444
- Pages
- 1561-1565
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W1993513102
- Cited by
- 484
- References
- 24
- FWCI
- 5.87
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.